Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis

被引：1
|
作者：
Di Raimondo, Cosimo [1 ]
Rao, Ludovico [1 ]
Lozzi, Flavia [1 ]
Lombardo, Paolo [1 ]
Silvaggio, Dionisio [1 ]
Vellucci, Laura [1 ]
Tofani, Lorenzo [1 ]
Campione, Elena [1 ]
Bianchi, Luca [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 05期
关键词：
D O I：
10.1111/dth.15421
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical and histopathological features of advanced cutaneous squamous cell carcinoma with varying responses to cemiplimab
    Hempel, Conrad
    Vladimirova, Gabriela
    Horn, Susanne
    Horn, Lars-Christian
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23 (01): : 30 - 37
  • [32] PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
    Migden, M. R.
    Rischin, D.
    Schmults, C. D.
    Guminski, A.
    Hauschild, A.
    Lewis, K. D.
    Chung, C. H.
    Hernandez-Aya, L.
    Lim, A. M.
    Chang, A. L. S.
    Rabinowits, G.
    Thai, A. A.
    Dunn, L. A.
    Hughes, B. G. M.
    Khushalani, N. I.
    Modi, B.
    Schadendorf, D.
    Gao, B.
    Seebach, F.
    Li, S.
    Li, J.
    Mathias, M.
    Booth, J.
    Mohan, K.
    Stankevich, E.
    Babiker, H. M.
    Brana, I.
    Gil-Martin, M.
    Homsi, J.
    Johnson, M. L.
    Moreno, V.
    Niu, J.
    Owonikoko, T. K.
    Papadopoulos, K. P.
    Yancopoulos, G. D.
    Lowy, I.
    Fury, M. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 341 - 351
  • [33] Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
    Bailly-Caille, Barbara
    Kottler, Diane
    Morello, Remy
    Lecornu, Marie
    Kao, William
    Meyer, Emmanuel
    Dompmartin, Anne
    L'Orphelin, Jean-Matthieu
    CANCERS, 2023, 15 (02)
  • [34] Treatment option for locally advanced cutaneous squamous cell carcinoma after cemiplimab resistance
    Peller, V.
    Mueller, C.
    Zillikens, H.
    Scheib, C.
    Viktoria, R.
    Roesch, A.
    Ugurel, S.
    Becker, J. C.
    Gutzmer, R.
    Schadendorf, D.
    Livingstone, E.
    Zimmer, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 72 - 72
  • [35] Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Swanson, Linnea
    Kassab, Ihab
    Tsung, Irene
    Worden, Francis P.
    Fontana, Robert J.
    IMMUNOTHERAPY, 2022, 14 (06) : 409 - 418
  • [36] Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
    Mager, Layna
    Gardeen, Samantha
    Carr, David R.
    Shahwan, Kathryn
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2135 - 2142
  • [37] High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
    Rischin, Danny
    Hughes, Brett G. M.
    Basset-Seguin, Nicole
    Schadendorf, Dirk
    Bowyer, Samantha
    Messai, Sabiha Trabelsi
    Meier, Friedegund
    Eigentler, Thomas K.
    Echarren, Victoria Casado
    Stein, Brian
    Beylot-Barry, Marie
    Dalac, Sophie
    Dreno, Brigitte
    Migden, Michael R.
    Hauschild, Axel
    Schmults, Chrysalyne D.
    Lim, Annette M.
    Yoo, Suk-Young
    Paccaly, Anne J.
    Papachristos, Apostolos
    Nguyen, Jenny-Hoa
    Okoye, Emmanuel
    Seebach, Frank
    Booth, Jocelyn
    Lowy, Israel
    Fury, Matthew G.
    Guminski, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
  • [38] Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma
    Ahmed, Saqib R.
    Petersen, Erik
    Patel, Ravi
    Migden, Michael R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (10) : 947 - 951
  • [39] Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme
    Garcia Castano, A.
    Munoz Couselo, E.
    Soria, A.
    Lavernia, J.
    Sanmartin, O.
    Canueto, J.
    Ayala de Miguel, P.
    Bea Ardebol, S.
    Bellido Hernandez, L.
    Fernandez-de-Misa Cabrera, R.
    Cunquero-Tomas, A. J.
    Fernandez Franco, L.
    Fernandez-Freire Leal, A.
    Mujika Eizmendi, K.
    Ortiz, C.
    Redondo, P.
    Romero, I.
    Serrano Fernandez, M.
    Medina Martinez, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S884 - S884
  • [40] Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma
    Hanania, Hannah L.
    Lewis, Daniel J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 237 - 238
12345